If You Invested in PARK HA BIOLOGICAL TECHNOLOGY (BYAH)

Park Ha Biological Technology Co., Ltd. (Nasdaq: BYAH) is a company whose business activities, according to available information, center on skincare and cosmetic products marketed under the Park Ha brand in China. The company is involved in developing its own private skincare label and distributing these products through direct sales and franchise-related promotion channels. Its brand positioning focuses on providing solutions for problematic skin, and its operating subsidiaries handle both product development and customer-facing services in physical locations.

Business focus and activities

Park Ha Biological Technology Co., Ltd. is engaged in the development of proprietary beauty and skincare products under the Park Ha name. Based on the available description, the company’s operating subsidiaries provide skincare and cosmetic products under this brand in China and are responsible for creating and refining the company’s own beauty formulations.

The company also conducts direct skincare product sales and participates in franchise alliances promotions. This indicates that, in addition to selling products directly, it works with franchise partners to promote its brand and offerings. Its physical stores provide complimentary after-sales beauty services, which are positioned as a way to support customers who use Park Ha products and to reinforce the brand’s focus on problematic skin.

Brand positioning

The Park Ha brand is described as focusing on solutions for problematic skin. Within this framework, the company emphasizes proprietary beauty products and after-sales beauty services offered in physical stores. These services are characterized as complimentary and are intended to support customers following their purchase of Park Ha skincare or cosmetic products.

Trading symbol and Nasdaq listing

Park Ha Biological Technology Co., Ltd. has announced that its ordinary shares trade on Nasdaq. The company stated that it would change its ticker symbol from PHH to BYAH, and that, effective on October 28, 2025, its ordinary shares would trade on Nasdaq under the new symbol BYAH. The company has indicated that its ordinary shares will continue to be listed on Nasdaq in connection with this symbol change and that the CUSIP will remain unchanged.

According to the company’s announcement, the purpose of the ticker symbol change is to prevent potential confusion with a previously delisted company that used the same symbol. The company also stated that it expects the change of ticker symbol to support the development of its long-term brand influence and brand value.

Corporate structure and operations

Available information notes that Park Ha Biological Technology Co., Ltd. operates through its operating subsidiaries, which develop proprietary beauty products and offer complimentary after-sales beauty services in physical stores. These subsidiaries are responsible for providing skincare and cosmetic products under the Park Ha brand in China.

The company’s activities, as described, combine product development, brand-focused marketing, and in-person services. Direct skincare product sales and franchise alliances promotions are mentioned as key channels through which the Park Ha brand is promoted and its products are brought to customers.

Investor considerations

From an investor information standpoint, Park Ha Biological Technology Co., Ltd. presents itself as a skincare and cosmetic products company with a specific focus on problematic skin and a brand-based strategy in China. Its Nasdaq listing under the symbol BYAH and the formal announcement of its ticker symbol change from PHH to BYAH are key structural details disclosed by the company.

Investors reviewing Park Ha Biological Technology Co., Ltd. can consider the company’s emphasis on proprietary product development, its use of physical stores to provide complimentary after-sales beauty services, and its reliance on both direct sales and franchise alliances promotions as described in available materials. The company has also publicly communicated that the ticker symbol change is intended to avoid confusion with a delisted company that previously used the same symbol and to support its brand-building efforts.